Cargando…

Natriuretic peptides in cardiovascular diseases

The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piechota, Mariusz, Banach, Maciej, Jacoń, Anna, Rysz, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SP Versita 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275881/ https://www.ncbi.nlm.nih.gov/pubmed/17965966 http://dx.doi.org/10.2478/s11658-007-0046-6

Ejemplares similares

N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients
por: Piechota, Mariusz, et al.
Publicado: (2006)

Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease
por: Chrusciel, Piotr, et al.
Publicado: (2014)

NATRIURETIC PEPTIDE SYSTEM AND CARDIOVASCULAR DISEASE
por: Federico, Cacciapuoti
Publicado: (2010)

Risk factors of hospitalisation in general surgery units: new application of International Classification of Diseases
por: Piechota, M, et al.
Publicado: (2008)

Prognostic value of plasma N-terminal pro-B-type natriuretic peptide concentration in patients with normal and impaired left ventricular systolic function undergoing surgery for abdominal aortic aneurysm
por: Waliszek, Marek, et al.
Publicado: (2011)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

Cardiovascular Pleiotropic Effects of Natriuretic Peptides
por: Forte, Maurizio, et al.
Publicado: (2019)

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
por: Nakagawa, Hitoshi, et al.
Publicado: (2022)

Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease
por: Stępień, Mariusz, et al.
Publicado: (2013)

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Diabetes and Cardiovascular Risk in Renal Transplant Patients
por: Rysz, Jacek, et al.
Publicado: (2021)

Prevention of sudden cardiac death in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2012)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Biological Role of Vitamin K—With Particular Emphasis on Cardiovascular and Renal Aspects
por: Stępień, Anna, et al.
Publicado: (2022)

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
por: Kerkelä, Risto, et al.
Publicado: (2015)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
por: Volpe, Massimo, et al.
Publicado: (2022)

The risk of atherosclerosis in patients with chronic kidney disease
por: Olechnowicz-Tietz, Sylwia, et al.
Publicado: (2013)

Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients – pilot study
por: Stępień, Mariusz, et al.
Publicado: (2012)

Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study
por: Stępień, Mariusz, et al.
Publicado: (2014)

Assessment of the Relationship between Lipid Parameters and Obesity Indices in Non-Diabetic Obese Patients: A Preliminary Report
por: Stępień, Anna, et al.
Publicado: (2014)

Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
por: Daniels, Lori B.
Publicado: (2010)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Heart function disturbances in chronic kidney disease – echocardiographic indices
por: Franczyk-Skóra, Beata, et al.
Publicado: (2014)

The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases
por: Rubattu, Speranza, et al.
Publicado: (2018)

Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise
por: de Almeida, Júlio C, et al.
Publicado: (2012)

CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System
por: Nakagawa, Yasuaki, et al.
Publicado: (2022)

Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions
por: Samad, Mohammad, et al.
Publicado: (2023)

The Importance of Natriuretic Peptides in Cardiometabolic Diseases
por: Vinnakota, Shravya, et al.
Publicado: (2020)

Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
por: deFilippi, Christopher R, et al.
Publicado: (2015)

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2018)

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
por: Dahdah, Nagib, et al.
Publicado: (2013)

Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
por: Rysz, Jacek, et al.
Publicado: (2020)

Atrial and Brain Natriuretic Peptides- Benefits and Limits of their use in Cardiovascular Diseases
por: Roxana, Mustafa Edme, et al.
Publicado: (2019)

The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
por: Femlak, Marek, et al.
Publicado: (2017)

Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021)

Blood Pressure Levels and Stroke: J-curve Phenomenon?
por: Malyszko, Jolanta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ocg51u4e1l0jm2tbpc19hcn4fs